The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
The Antiphospholipid Syndrome
Abstract
The antiphospholipid syndrome is an autoimmune disorder of hypercoagulability characterized by the presence of autoantibodies to various phospholipids or phospholipid-binding proteins. The autoantibodies include anticardiolipin antibodies, lupus anticoagulant antibodies, and antibodies to β2-glycoprotein I (a phospholipid-binding protein). These autoantibodies have both procoagulant and anticoagulant effects, but the procoagulant effects predominate, resulting in syndromes of venous and arterial thrombosis and pregnancy loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McNeil, H. P., Simpson, R. J., Chesterman, C. N., & Krilis, S. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4120 · Cited by 1,595
The management of thrombosis in the antiphospholipid-antibody syndrome
Khamashta, M. A., Cuadrado, M. J., Mujic, F., Taub, N. A., Hunt, B. J., & Hughes, G. R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321504 · Cited by 1,450
Harris, E. N., Boey, M. L., Mackworth-Young, C. G., Gharavi, A. E., Patel, B. M., Loizou, S., & Hughes, G. R. V. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91267-9 · Cited by 1,383
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
Galli, M., Barbui, T., Comfurius, P., Maassen, C., Hemker, H. C., Zwaal, R. F. A., Bevers, E. M., de Baets, M. H., & van Breda-Vriesman, P. J. C. (1990) · The Lancet · doi:10.1016/0140-6736(90)91374-j · Cited by 1,270
Brandt, J. T., Triplett, D. A., Alving, B. M., & Scharrer, I. (1995) · PubMed · Cited by 1,164
Rai, R., Cohen, H., Dave, M., & Regan, L. (1997) · BMJ · doi:10.1136/bmj.314.7076.253 · Cited by 1,113
Love, P. E., & Santoro, S. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-682 · Cited by 1,095
Brandt, J. T., Triplett, D. A., Alving, B., & Scharrer, I. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649901 · Cited by 993
CERVERA, R., KHAMASHTA, M. A., FONT, J., SEBASTIANI, G. D., GIL, A., LAVILLA, P., DOMÉNECH, I., AYDINTUG, A. O., JEDRYKA-GÓRAL, A., RAMÓN, E. D., et al. (1993) · Medicine · doi:10.1097/00005792-199303000-00005 · Cited by 979
The “Primary” Antiphospholipid Syndrome: Major Clinical and Serological Features
ASHERSON, R. A., KHAMASHTA, M. A., ORDI-ROS, J., DERKSEN, R. H. W. M., MACHIN, S. J., BARQUINERO, J., OUTT, H. H., HARRIS, E. N., VILARDELL-TORRES, M., & HUGHES, G. R. V. (1989) · Medicine · doi:10.1097/00005792-198911000-00004 · Cited by 959
The "primary" antiphospholipid syndrome: major clinical and serological features.
Asherson, R. A., Khamashta, M. A., Ordi‐Ros, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · PubMed · Cited by 892
(2011) · SpringerReference · doi:10.1007/springerreference_40291 · Cited by 829
Kutteh, W. H. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70610-5 · Cited by 803
Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients
Rosove, M. H., & Brewer, P. M. C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-303 · Cited by 700 · cited 2×
“Three retrospective studies have shown a beneficial role of anticoagulation (17, 18, 19).”
BackgroundALARCÓN-SEGOVIA, D., DELEZÉ, M., ORIA, C. V., SÁNCHEZ-GUERRERO, J., GÓMEZ-PACHECO, L., CABIEDES, J., FERNÁNDEZ, L., & DE LEÓN, S. P. (1989) · Medicine · doi:10.1097/00005792-198911000-00003 · Cited by 639
Cowchock, F. S., Reece, E. A., Balaban, D., Branch, D. W., & Plouffe, L. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91596-3 · Cited by 591
Self-citationLockshin, M. D., Druzin, M. L., Goei, S., Qamar, T., Magid, M. S., Jovanovic, L., & Ferenc, M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507183130304 · Cited by 583
Bevers, E. M., Galli, M., Barbui, T., Comfurius, P., & Zwaal, R. F. A. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646476 · Cited by 576
Catastrophic Antiphospholipid Syndrome: Clinical and Laboratory Features of 50 Patients
Asherson, R. A., Cervera, R., Piette, J.-C., Font, J., Lie, J. T., Burcoglu, A., Lim, K., Muñoz-Rodríguez, F. J., Levy, R. A., Boué, F., et al. (1998) · Medicine · doi:10.1097/00005792-199805000-00005 · Cited by 544
Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis
Ginsburg, K. S., Liang, M. H., Newcomer, L., Goldhaber, S. Z., Schur, P. H., Hennekens, C. H., & Stampfer, M. J. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-997 · Cited by 526 · cited 1×
“Aspirin 325 mg/day did not protect male physicians with ACA against deep vein thrombosis and pulmonary embolism (15).”
BackgroundPregnancy Loss in the Antiphospholipid-Antibody Syndrome — A Possible Thrombogenic Mechanism
Rand, J. H., Wu, X.-X., Andree, H. A. M., Lockwood, C. J., Guller, S., Scher, J., & Harpel, P. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370303 · Cited by 526
Schulman, S., Svenungsson, E., & Granqvist, S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00060-6 · Cited by 497
Oosting, J., Derksen, R., Bobbink, I., Hackeng, T., Bouma, B., & de Groot, P. (1993) · Blood · doi:10.1182/blood.v81.10.2618.2618 · Cited by 488
Immunology and clinical importance of antiphospholipid antibodies
McNeil, H. P., Chesterman, C. N., & Krilis, S. A. (1991) · Advances in immunology · doi:10.1016/s0065-2776(08)60777-4 · Cited by 481
Epidemiology of the Antiphospholipid Antibody Syndrome
Petri, M. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0409 · Cited by 472
Vianna, J. L., Khamashta, M. A., Ordi-Ros, J., Font, J., Cervera, R., Lopez-Soto, A., Tolosa, C., Franz, J., Selva, A., Ingelmo, M., et al. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90108-2 · Cited by 470
(1992) · PubMed · Cited by 434
Finazzi, G., Brancaccio, V., Moia, M., Ciavarella, N., Mazzucconi, M. G., Schinco, P., Ruggeri, M., Pogliani, E. M., Gamba, G., Rossi, E., et al. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00060-5 · Cited by 427
Clifford, K., Rai, R., Watson, H., & Regan, L. (1994) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a138703 · Cited by 427
De Wolf, F., Carreras, L. O., Moerman, P., Vermylen, J., Van Assche, A., & Renaer, M. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)32527-3 · Cited by 411
Vaarala, O., Aho, K., Palosuo, T., Alfthan, G., Jauhiainen, M., & Leirisalo-Repo, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)91213-6 · Cited by 409
Antiphospholipid Antibodies and venous thromboembolism
Ginsberg, J., Wells, P., Brill-Edwards, P., Donovan, D., Moffatt, K., Johnston, M., Stevens, P., & Hirsh, J. (1995) · Blood · doi:10.1182/blood.v86.10.3685.bloodjournal86103685 · Cited by 365
Eine serodiagnostische Reaktion bei Syphilis
Wassermann, A., Neisser, A., & Bruck, C. (1906) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0028-1142018 · Cited by 361
Hörkkö, S., Miller, E., Dudl, E., Reaven, P., Curtiss, L. K., Zvaifler, N. J., Terkeltaub, R., Pierangeli, S. S., Branch, D. W., Palinski, W., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118854 · Cited by 348
Self-citationPrimary Antiphospholipid Syndrome
(2020) · Frontiers Research Topics · doi:10.3389/978-2-88966-108-4 · Cited by 346
Branch, D. W., Peaceman, A. M., Druzin, M., Silver, R. K., El-Sayed, Y., Silver, R. M., Esplin, M. S., Spinnato, J., & Harger, J. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(00)70500-x · Cited by 318
Self-citationVaarala, O., Mänttäri, M., Manninen, V., Tenkanen, L., Puurunen, M., Aho, K., & Palosuo, T. (1995) · Circulation · doi:10.1161/01.cir.91.1.23 · Cited by 317
Di Simone, N., Meroni, P. L., Del Papa, N., Raschi, E., Caliandro, D., De Carolis, S., Khamashta, M. A., Atsumi, T., Hughes, G. R. V., Balestrieri, G., et al. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<140::aid-anr18>3.0.co;2-p · Cited by 316
(1996) · PubMed · Cited by 307
The Intrarenal Vascular Lesions Associated with Primary Antiphospholipid Syndrome
NOCHY, D., DAUGAS, E., DROZ, D., BEAUFILS, H., GRÜNFELD, J.-P., PIETTE, J.-C., BARIETY, J., & HILL, G. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v103507 · Cited by 307
OutiVaarala, MattiMänttäri, VesaManninen, LeenaTenkanen, MarjaPuurunen, KimmoAho, & TimoPalosuo (1995) · Circulation · Cited by 305
Immunology of the antiphospholipid antibody syndrome
Roubey, R. A. S. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390903 · Cited by 302
Pattison, N. S., Chamley, L. W., Birdsall, M., Zanderigo, A. M., Liddell, H. S., & McDougall, J. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.106754 · Cited by 291
Wahl, D., Guillemin, F., de Maistre, E., Perret, C., Lecompte, T., & Thibaut, G. (1997) · Lupus · doi:10.1177/096120339700600510 · Cited by 285 · cited 1×
“It was also shown (17, 18, 19, 20) that discontinuation of anticoagulants seems to be associated with an increased risk of thrombosis (up to 70 %), and even death, especially in the first six months : anticoagulation should therefore be long term, if not lifelong.”
BackgroundUse of Antithrombotic Agents During Pregnancy
Ginsberg, J. S., Greer, I., & Hirsh, J. (2001) · Chest · doi:10.1378/chest.119.1_suppl.122s · Cited by 280
Alarcón-Segovia, D., Pérez-Vázquez, M. E., Villa, A. R., Drenkard, C., & Cabiedes, J. (1992) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(92)90021-5 · Cited by 273
Viard, J.-P., Amoura, Z., & Bach, J.-F. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90049-h · Cited by 264
Hunt, J. E., McNeil, H. P., Morgan, G. J., Crameri, R. M., & Krilis, S. A. (1992) · Lupus · doi:10.1177/096120339200100204 · Cited by 257
A New Serologically Active Phospholipid from Beef Heart
Pangborn, M. C. (1941) · Experimental Biology and Medicine · doi:10.3181/00379727-48-13365p · Cited by 250
Derksen, R. H., de Groot, P. G., Kater, L., & Nieuwenhuis, H. K. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.9.689 · Cited by 242
β2-glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles
Wurm, H. (1984) · International Journal of Biochemistry · doi:10.1016/0020-711x(84)90168-x · Cited by 234
Antiphospholipid antibodies and fetal death
OSHIRO, B., SILVER, R., SCOTT, J., YU, H., & WAREBRANCH, D. (1996) · Obstetrics & Gynecology · doi:10.1016/0029-7844(95)00498-x · Cited by 230
Preboth, M. (2000) · PubMed · Cited by 218
Monitoring Warfarin Therapy in Patients with Lupus Anticoagulants
Moll, S., & Ortel, T. L. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-3-199708010-00001 · Cited by 214
Yetman, D. L., & Kutteh, W. H. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58565-3 · Cited by 208
Price, B. E., Rauch, J., Shia, M. A., Walsh, M. T., Lieberthal, W., Gilligan, H. M., O'Laughlin, T., Koh, J. S., & Levine, J. S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.2201 · Cited by 206
Self-citationErkan, D., Merrill, J. T., Yazici, Y., Sammaritano, L., Buyon, J. P., & Lockshin, M. D. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200106)44:6<1466::aid-art242>3.0.co;2-c · Cited by 193
Measurement of anti-phospholipid antibodies by ELISA using β2-glycoprotein I as an antigen
Arvieux, J., Roussel, B., Jacob, M. C., & Colomb, M. G. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90047-j · Cited by 188
Merkel, P. A., Chang, Y., Pierangeli, S. S., Convery, K., Nigel Harris, E., & Polisson, R. P. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00335-x · Cited by 178
Galli, M., Comfurius, P., Barbui, T., Zwaal, R. F. A., & Bevers, E. M. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656368 · Cited by 174
Thrombotic Storm: When Thrombosis Begets Thrombosis
Kitchens, C. S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00061-8 · Cited by 169
Meroni, P. L., Raschi, E., Camera, M., Testoni, C., Nicoletti, F., Tincani, A., Khamashta, M. A., Balestrieri, G., Tremoli, E., & Hess, D. C. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0412 · Cited by 163
Biochemical characterization of ADP-ribose polymer metabolism in SLE
Chen, H.-Y., Pertusi, R., Kirkland, J., Rubin, B., & Jacobson, E. (1996) · Lupus · doi:10.1177/096120339600500105 · Cited by 162
Crofford, L. J., Oates, J. C., McCune, W. J., Gupta, S., Kaplan, M. J., Catella-Lawson, F., Morrow, J. D., McDonagh, K. T., & Schmaier, A. H. (2000) · Arthritis & Rheumatism · Cited by 152
Arnout, J. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650316 · Cited by 147
Kincaid‐Smith, P., Fairley, K. F., & Kloss, M. (1988) · QJM · doi:10.1093/oxfordjournals.qjmed.a068246 · Cited by 146
WAREBRANCH, D., SILVER, R., Pierangeli, S. S., VANLEEUWEEN, I., & Nigelharris, E. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(97)00065-3 · Cited by 138
Haserick, J. R., & LONG, R. (1952) · Annals of Internal Medicine · doi:10.7326/0003-4819-37-3-559 · Cited by 127
Exclusion criteria for primary antiphospholipid syndrome.
Pietté, J. C., Wechsler, B., Francès, C., Papo, T., & Godeau, P. (1993) · PubMed · Cited by 110
Cabral, A. R., Amigo, M., Cabiedes, J., & Alarcón-Segovia, D. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00254-9 · Cited by 101
Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome
Hughson, M. D., McCarty, G. A., & Brumback, R. A. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90218-x · Cited by 96
Stroke and Parkinson's disease.
Levine, R. L., Jones, J. C., & Bee, N. (1992) · Stroke · doi:10.1161/01.str.23.6.839 · Cited by 88
Kandiah, D. A., & Krilis, S. A. (1994) · Lupus · doi:10.1177/096120339400300401 · Cited by 85
Which are the Best Biological Markers of the Antiphospholipid Syndrome?
Carreras, L. O., Forastiero, R. R., & Martinuzzo, M. E. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0401 · Cited by 79
Induction of Anti-Phospholipid Autoantibodies by β2-glycoprotein I Bound to Apoptotic Thymocytes
Levine, J. S., Subang, R., Koh, J. S., & Rauch, J. (1998) · Journal of Autoimmunity · doi:10.1006/jaut.1998.0235 · Cited by 76
Self-citationAntiphospholipid Antibodies, Recurrent Thromboembolism, and Intensity of Warfarin Anticoagulation
Prandoni, P., Simioni, P., & Girolami, A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650380 · Cited by 76
Anticardiolipin Antibodies and Recurrent Thromboembolism
Rance, A., Emmerich, J., & Fiessinger, J. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655939 · Cited by 70
Tissue Factor Pathway and the Antiphospholipid Syndrome
Roubey, R. A. S. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0397 · Cited by 52
Should we Include Anti-prothrombin Antibodies in the Screening for the Antiphospholipid Syndrome?
Galli, M. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0413 · Cited by 51
Alsayegh, F., Ensworth, S., Huang, S., STEIN, H. B., & Klinkhoff, A. V. (1997) · PubMed · Cited by 41
Crowther, M., Julian, J., Stewart, K., Donovan, D., Kaminska, E., Laskin, C., Ginsberg, J., & Douketis, J. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614324 · Cited by 27
Triplett, D. A. (1999) · Springer eBooks · doi:10.1007/978-94-011-4722-4_19 · Cited by 2
Wilson (1999) · doi:10.1002/1529-0131(199907)42:7<1309::aid-anr1>3.0.co;2-f
Cited by
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Self-citationRisk Factors for Venous Thromboembolism
Anderson, F. A., & Spencer, F. A. (2003) · Circulation · doi:10.1161/01.cir.0000078469.07362.e6 · Cited by 1,652
Natural History of Venous Thromboembolism
Kearon, C. (2003) · Circulation · doi:10.1161/01.cir.0000078464.82671.78 · Cited by 1,048
Cardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis
Ageno, W., Becattini, C., Brighton, T., Selby, R., & Kamphuisen, P. W. (2008) · Circulation · doi:10.1161/circulationaha.107.709204 · Cited by 974
Premature Coronary-Artery Atherosclerosis in Systemic Lupus Erythematosus
Asanuma, Y., Oeser, A., Shintani, A. K., Turner, E., Olsen, N., Fazio, S., Linton, M. F., Raggi, P., & Stein, C. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035611 · Cited by 892
Metadata
- Authors
- Levine, J. S., Branch, D. W., & Rauch, J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-03-07
- Volume
- 346
- Issue
- 10
- Pages
- 752-763
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3021852519
- Cited by
- 1,543
- References
- 84
- FWCI
- 72.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.